Director, Research and Preclinical Development

The Director, Research & Preclinical Development, reporting to the Chief Operating Officer, will provide leadership for the strategic nonclinical development of EHP drug candidates.

He/she will work collaboratively with internal and external teams, and collaborators/ consultants to plan and execute the overall preclinical development of drug candidates.  He/she will support the testing of EHP’s drug candidates in various animal models and design, execute, interpret and report nonclinical studies conducted in various species under non-GLP and GLP conditions.

He/she will generate comprehensive reports that assess the pharmacological and toxicological profile of drug candidates, and investigate toxicity relationships.

He/she will present studies analyses and interpretations to regulatory agencies in meetings and documents including the IND/CTA, annual reports, investigator brochures, special protocol assessments and market applications. He/she will represent EHP at conferences and present findings internally and externally.

He/she will need to be a champion for innovation and lean product development as well as maintain contact with the scientific and pharmaceutical communities to stay current in the field and industry.